4//SEC Filing
Culwell Kelly 4
Accession 0001618835-21-000007
CIK 0001618835other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:54 PM ET
Size
7.1 KB
Accession
0001618835-21-000007
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2021-02-03+150,000→ 150,000 totalExercise: $3.25Exp: 2031-02-03→ Common Stock (150,000 underlying) - Award
Common Stock
2021-02-03+200,000→ 315,451 total
Footnotes (2)
- [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726183
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:54 PM ET
- Size
- 7.1 KB